Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa

Author： Hymes Jeffrey   Bickimer Tammy   Jackson James H.   Bookhart Brahim K.   Mody Samir H.   Tak Piech Catherine  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.8, 2007-08, pp. : 1931-1937

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease

By Cremieux Pierre-Yves   Van Audenrode Marc   Lefebvre Patrick  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2329-2336

Informa Healthcare

Access to resources Recommend Favorite

Comment on: The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease

By Einarson Thomas   Machado Marcio   Walker John   Iskedjian Michael   Cremieux Pierre-Yves   Van Audenrode Marc   Lefebvre Patrick  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1571-1574

Informa Healthcare

Access to resources Recommend Favorite

Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa

By Lefebvre Patrick   Vekeman Francis   Sarokhan Brenda   Enny Christopher   Provenzano Robert   Cremieux Pierre-Yves  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 1929-1937

Informa Healthcare

Access to resources Recommend Favorite

Preference for monthly darbepoetin alfa dosing in patients with chronic kidney disease not receiving dialysis

By Hoggard Jeffrey   Crouch Thomas   McMurray Stephen   Levine Michael   Prathikanti Radha   Scarlata Debra   Audhya Paul  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2023-2030

Informa Healthcare

Access to resources Recommend Favorite

A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease

By Roger Simon D.   Suranyi Michael G.   Walker Rowan G.    

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2181-2187

Informa Healthcare

Access to resources Recommend Favorite